CHINET 2008 surveillance of bacterial resistance in China

Chinese Journal of Infection and Chemotherapy

Volumn 9, Issue 5, 2009, Pages 321-329

  Wang, Fu ^a   Zhu, De Mei ^a   Hu, Fu Pin ^a   Ruan, Fei Yi ^a   Ni, Yu Xing ^a   Sun, Jing Yong ^a   Xu, Ying Chun ^a   Zhang, Xiao Jiang ^a   Hu, Yun Jian ^a   Ai, Xiao Man ^a   Yu, Yun Song ^a   Yang, Qing ^a   Sun, Zi Yong ^a   Jian, Cui ^a   Jia, Bei ^a   Huang, Wen Xiang ^a   Zhuo, Chao ^a   Su, Dan Hong ^a   Wei, Lian Hua ^a   Wu, Ling ^a   Zhang, Chao Xia ^a   Ji, Ping ^a   Wang, Chuan Qing ^a   Xue, Jian Chang ^a   Zhang, Hong ^a   Li, Wang Hua ^a   more..

^a FUDAN UNIVERSITY   (China)

Author keywords

Bacterial susceptibility testing; Extended spectrum beta lactamases; Methicillin resistant Staphylococcus; Multi drug resistance strain; Pan resistant strain; Surveillance of bacterial resistance; Vancomycin resistant Enterococcus

Indexed keywords

BETA LACTAM; CHLORAMPHENICOL; COAGULASE; COTRIMOXAZOLE; FOSFOMYCIN; IMIPENEM; LINEZOLID; MEROPENEM; MINOCYCLINE; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BURKHOLDERIA; CHINA; DRUG ACTIVITY; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; GENERAL HOSPITAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PEDIATRIC HOSPITAL; PHENOTYPE; SPECIES; STAPHYLOCOCCUS;

EID: 70349562558     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Clinical and Laboratory Standards Institute(CLSI). Performance standards for Antimicrobial susceptibility testing[S]. M100-S17, 2007.
2. Clinical and Laboratory Standards Institute (CLSI). Performance standards for Antimicrobial susceptibility testing[S]. M100-S19, 2009.
3. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium[J]. Arch Int Med, 2005,165(12):1430-1435. (Pubitemid 40973427)
4. Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA[J]. J Antimicrob Chemother, 2009,63(3):427-437.
5. Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea[J]. J Clin Microbiol, 2005,43(5):2241-2245. (Pubitemid 40656234)
6. Naas T, Levy M, Hirschauer C, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Pepcete, French Polynesta[J]. J Clin Microbiol, 2005,43(9):4826- 4829. (Pubitemid 41298286)
7. Waites KB, Duffy LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial[J]. Antimicrob Agents Chemother, 2006,50(10):3479-3484.
8. Souli M, Kontopidou FV, Koratzanis E, et al. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, Gram-negative and Gram-positive clinical isolates from Greek hospitals[J]. Antimicrob Agents Chemother, 2006,50(9):3166-3169.
9. Gordon NC, Wareham DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline[J]. J Antimicrob Chemother, 2009,63(4):775-780.